Home/Filings/4/0001225208-24-003054
4//SEC Filing

SAHNI PAYAL 4

Accession 0001225208-24-003054

CIK 0000078003other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 1:46 PM ET

Size

10.8 KB

Accession

0001225208-24-003054

Insider Transaction Report

Form 4
Period: 2024-02-23
SAHNI PAYAL
Executive Vice President
Transactions
  • Tax Payment

    Common Stock

    2024-02-23$27.76/sh905$25,12333,699 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-02-2311,5270 total
    Exercise: $27.34From: 2024-02-23Exp: 2024-02-23Common Stock (11,527 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-23$27.34/sh+11,527$315,14834,604 total
  • Tax Payment

    Common Stock

    2024-02-23$27.37/sh9,314$254,92424,385 total
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    11,405
Footnotes (4)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001817124

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 1:46 PM ET
Size
10.8 KB